Assistant Professor, Immunoengineering

Position Overview

The Schulich School of Engineering, in partnership with the Riddell Centre for Cancer Immunotherapy/Charbonneau Cancer Institute, Alberta Children’s Hospital Research Institute (ACHRI), and the Snyder Institute at the University of Calgary, invites national and international applications for a full-time, tenure‑track position at the rank of Assistant Professor, anticipated start date of May 1, 2026.

The successful candidate will be appointed as a tenure‑track Assistant Professor in the Department of Biomedical Engineering. The candidate may be encouraged to join the Charbonneau Cancer Institute, ACHRI and/or Snyder Institute, depending on research interests. The role will contribute to research, student and postdoctoral supervision, undergraduate and graduate teaching, curriculum development, and service to the department, faculty and university.

• Establish a strong research program in Immunoengineering with potential for national and international recognition within five to ten years.
• Attract competitive external funding and recruit excellent trainees and staff.
• Contribute to undergraduate and graduate teaching in areas aligned with expertise.
• Provide service to the department, faculty, institutes, university, and broader community.
• Advocate for equitable, diverse, inclusive, and accessible employment practices.
• Over time, assume leadership roles within the department, school and university.

• Doctoral degree (or equivalent) in engineering, life sciences or a related discipline.
• Bachelor’s degree in engineering or equivalent.
• Emerging scholarly profile with an original, creative, innovative, and forward‑looking research program recognized by peers.
• Potential for synergies with existing researchers and research groups across campus.
• Expected to be or become eligible for registration as a professional engineer with the Association of Professional Engineers and Geoscientists of Alberta (APEGA).

The research program will broadly address immune‑related engineering (immunoengineering). Possible topics include:

• Biomimetic materials
• Immuno‑oncology
• Molecular engineering
• Synthetic biology
• Cell‑based therapies
• Systems immunology and computational immunoengineering
• Biomanufacturing
• Regenerative immunology
• Advanced in‑vitro model systems such as organ‑on‑chip and microphysiological platforms
• Translational applications for vaccine design, immunomodulatory biomaterials, diagnostics and therapeutics

Interested candidates should submit an application online via the ‘Apply Now’ link, ensuring only four attachments, organized as follows (documents may be merged as needed):

• Cover letter and curriculum vitae, plus name and contact information of three referees
• Statement of research interests, accomplishments and vision (maximum 2 pages)
• Statement of teaching philosophy promoting student learning and success (maximum 2 pages)
• Statement on equity, diversity and inclusion (maximum 2 pages)

Applications are accepted until April 1, 2026.

Questions may be addressed to:
Dr. Michael Kallos
Head, Department of Biomedical Engineering
Email:

The University of Calgary is an equitable and inclusive employer committed to removing barriers historically encountered by some members of society. We encourage applicants from designated groups—including women, Indigenous peoples, persons with disabilities, visible/racialized minorities, and diverse sexual orientations and gender identities—to apply. Canadians and permanent residents will be given priority. Accommodation at any stage of the recruitment process is available for applicants with disabilities.

For diversity and equity inquiries, contact the Office of Institutional Commitments () and for accommodation requests, contact People & Culture ().